May 2016

Bliss GVS is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. We are a public limited company listed on India’s National Stock Exchange and Bombay Stock Exchange with more than three decades of industry expertise. We are among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. Our thirty years of experience in suppositories manufacturing has resulted in developing an extensive product offering in suppositories and pessaries across various therapeutic categories (see here). We follow European GMP Standards for manufacturing suppositories.

Post: International Business Development

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: Clinical Data Manager

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Bhupender Singh, Arun Nanda, Vikaas Budhwar, Rakesh K. Marwaha
Department of Pharmacy,
M. D. University, Rohatak
Haryana, India
* pharma.bsingh@gmail.com

ABSTRACT
Generic drugs are as effective as their branded counterparts in terms of safety and efficacy. Although their exists several myths about quality of generic medicines because of its less price as compared to branded counterparts. The present study aims to evaluate and compare the quality of generic medicine with their branded counterparts as per Indian Pharmacopoeial standards and other validated methods on a commonly used type 2 diabetes drug (Metformin). The qualitative as well as quantitative studies were performed as per IP 2010. The official test performed includes uniformity of weight, disintegration, dissolution, assay and friability. Non official test includes hardness test and assay by HPLC using validated methods. The study revealed that branded as well as generic metformin tablets comply with the standards provided in IP 2010 and generic metformin was found to be 111.52% lesser in cost per tablet as compared to costliest branded version of metformin.